COVID-19 leads to hydroxychloroquine shortage for patients with autoimmune disease
COVID-19 leads to hydroxychloroquine shortage for patients with autoimmune disease

It's been six years since Elizabeth Wallington Thorne was diagnosed with rheumatoid arthritis.

An athlete, who used to run marathons, Wallington Thorne said her symptoms started with widespread pain.